The clinical spectrum of pulmonary aspergillosis

Chest

Volumn 121, Issue 6, 2002, Pages 1988-1999

  Soubani, Ayman O ^a   Chandrasekar, Pranatharthi H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic pulmonary aspergillosis; Aspergillus; Fungal diseases; Immunocompromised host; Pulmonary infection

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTITUSSIVE AGENT; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN B; FLUCYTOSINE; FUNGUS ANTIGEN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; PREDNISONE; RIFAMPICIN; VORICONAZOLE;

ALLERGIC PNEUMONITIS; ASPERGILLUS; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CAUSE OF DEATH; CHRONIC LUNG DISEASE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG BIOAVAILABILITY; ELECTROLYTE DISTURBANCE; FATALITY; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY REACTION; IMAGE ANALYSIS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; LUNG GRANULOMATOSIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0036283440     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.6.1988     Document Type: Review

References (145)

1. Invasive aspergillosis
2. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma
3. Aspergilloma consequent to allergic bronchopulmonary aspergillosis
4. Aspergilloma and residual tuberculous cavities: The results of a resurvey
5. Quandary about treatment of aspergillomas persists
6. Pulmonary aspergillosis complicating ankylosing spondylitis
7. Clinical evaluation of 61 patients with pulmonary aspergilloma
8. Cavitary pulmonary cryptococcosis complicated by aspergilloma
9. Aspergillomas occurring in blastomycotic cavities
10. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases
11. The spectrum of pulmonary aspergillosis
12. Aspergillus in persistent lung cavities after tuberculosis: A report from the Research Committee of the British Tuberculosis Association
13. Hemoptysis and pulmonary aspergilloma: Operative versus nonoperative treatment
14. Pulmonary aspergilloma and AIDS: A comparison of HIV-infected and HIV-negative individuals
15. Aspergillosis of the lung: An eighteen-year experience
16. The surgical treatment of pulmonary aspergillomas
17. Pulmonary aspergilloma: Results of surgical treatment
18. Pulmonary aspergillosis: An analysis of 41 patients
19. Pulmonary aspergilloma: Analysis of prognosis in relation to haemoptysis and survey of treatment
20. Pulmonary aspergilloma: Diagnostic and therapeutic considerations
21. Practice guidelines for diseases caused by Aspergillus: Infectious Diseases Society of America
22. Pulmonary air meniscus sign
23. Intrathoracic aspergilloma: Role of CT in diagnosis and treatment
24. Cavitary lung cancer with an aspergilloma-like shadow
25. Pulmonary aspergilloma complicating Wegener's granulomatosis
26. Pulmonary aspergilloma: Clinical immunology
27. Aspergillus lung disease
28. Topical treatment of pulmonary aspergilloma by antifungals: Relationship between duration of the disease and efficacy of therapy
29. Intracavitary aspergilloma: Transthoracic percutaneous injection of amphotericin gelatin solution
30. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis
31. Itraconazole therapy in aspergillosis: Study in 49 patients
32. Treatment of pulmonary aspergilloma with itraconazole
33. Treatment of aspergillosis with itraconazole
34. Bronchial artery embolization in the management of hemoptysis: Technical aspects and long-term results
35. Surgical treatment of pulmonary aspergilloma
36. Pleuropulmonary aspergilloma: Clinical spectrum and results of surgical treatment
37. Surgery for pulmonary aspergillosis
38. Surgical treatment for pulmonary aspergilloma: A 28 year experience
39. Aspergilloma: A series of 89 surgical cases
40. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entity
41. “Semi-invasive” pulmonary aspergillosis: A new look at the spectrum of Aspergillus infections of the lung
42. Chronic necrotizing aspergillosis: Approach to management
43. Chronic necrotizing pulmonary aspergillosis and pulmonary phycomycosis in cystic fibrosis
44. Chronic necrotizing pulmonary aspergillosis: Pathologic outcome after itraconazole therapy
45. Aspergillosis update
46. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
47. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
48. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon
49. Invasive aspergillosis in patients with AIDS
50. Clinical aspects of fungal infection in organ transplant recipients
51. Pulmonary aspergillosis in the acquired immunodeficiency syndrome
52. Pulmonary complications of bone marrow transplantation
53. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
54. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience
55. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study
56. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases; French Cooperative Study Group on Aspergillosis in AIDS
57. Pulmonary aspergillosis in patients with AIDS: Clinical and radiographic correlations
58. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS
59. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts
60. Changing patterns of aspergillosis infections
61. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
62. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: Benefits of intensive care?
63. Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes; I3 Aspergillus Study Group
64. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature
65. Aspergillosis: The spectrum of the disease in 98 patients
66. Invasive aspergillosis
67. Primary cutaneous aspergillosis associated with Hickman intravenous catheters
68. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis: Influence of bone marrow recovery in patients with acute leukemia
69. Endobronchial lesions in HIV-infected individuals
70. Aspergillus and endobronchial abnormalities in lung transplant recipients
71. Invasive aspergillosis
72. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: Results from a three-year prospective study
73. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis
74. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
75. Diagnosing fungal infections in immunocompromised hosts
76. Aspergillus fungemia: Report of two cases and review
77. Aspergillosis and mucormycosis: Two types of opportunistic fungal pneumonia
78. Opportunistic fungal pneumonias in cancer patients
79. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
80. CT of invasive pulmonary aspergillosis
81. Invasive pulmonary aspergillosis in acute leukemia: The contribution of CT to early diagnosis and aggressive management
82. Air crescent sign of invasive aspergillosis
83. Invasive pulmonary aspergillosis and acute leukemia: Limitations in the diagnostic utility of the air crescent sign
84. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
85. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia
86. Open lung biopsy in patients with acute leukemia
87. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation
88. Value of antigen detection in predicting invasive pulmonary aspergillosis
89. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis: Preliminary investigations with two examples
90. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients
91. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis
92. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis
93. General primer-mediated PCR for detection of Aspergillus species
94. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR
95. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis
96. Pulmonary aspergillosis: Early diagnosis improves survival
97. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
98. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia
99. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases
100. Therapeutic outcome in invasive aspergillosis
101. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
102. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant
103. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-centre experience of 133 episodes in 116 patients
104. Liposomal amphotericin B (AmBi-some) therapy in invasive fungal infections: Evaluation of United Kingdom compassionate use data
105. Treatment of invasive aspergillosis with itraconazole
106. Amphotericin B refractory aspergillosis after itraconazole: Evidence for significant antagonism
107. New type of antifungal approved for invasive aspergillosis
108. Fatal haemoptysis in pulmonary filamentous mycosis: An underevaluated cause of death in patients with acute leukaemia in haematological complete remission; a retrospective study and review of the literature - Gimema Infection Program
109. Surgical management of invasive pulmonary aspergillosis in neutropenic patients
110. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
111. Pulmonary resection for invasive Aspergillus infections in immunocom-promised patients
112. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease
113. Impact of air filtration on nosocomial Aspergillus infections: Unique risk of bone marrow transplant recipients
114. Antifungal prophylaxis in neutropenic patients with hematologic malignancies
115. Febrile neutropenia: Antifungal prophylaxis
116. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics
117. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
118. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis
119. Allergic bronchopulmonary aspergillosis
120. In vitro T cell responses in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis
121. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis
122. Pathologic features of allergic bronchopulmonary aspergillosis
123. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis
124. The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis
125. Diagnosis and management of allergic bronchopulmonary aspergillosis
126. Allergic bronchopulmonary aspergillosis: Clinical perspectives
127. Immunologic aspects of lung diseases and cystic fibrosis
128. Allergic bronchopulmonary aspergillosis: Staging as an aid to management
129. Allergic bronchopulmonary aspergillosis: Natural history and classification of early disease by serologic and roentgenographic studies
130. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis
131. The management of allergic bronchopulmonary aspergillosis
132. Corticosteroid treatment and prognosis in pulmonary eosinophilia
133. Five-year follow-up of allergic bronchopulmonary aspergillosis
134. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis: Report to the Research Committee of the British Thoracic Association
135. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis
136. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis
137. Possible mucoid impaction of allergic bronchopulmonary aspergilloma
138. Hemoptysis and a lung mass in a 51-year-old patient with asthma
139. Bronchocentric granulomatosis and allergic bronchopulmonary aspergillosis
140. Chronic eosinophilic pneumonia, a manifestation of allergic aspergillosis
141. Chronic eosinophilic pneumonia: A report of 19 cases and a review of the literature
142. Hypersensitivity pneumonitis
143. Guidelines for the clinical evaluation of hypersensitivity pneumonitis: Report of the Subcommittee on Hypersensitivity Pneumonitis
144. Hypersensitivity pneumonitis in workers exposed to esparto grass (Stipa tenacissima) fibers
145. Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung